1. Home
  2. USAS vs ATAI Comparison

USAS vs ATAI Comparison

Compare USAS & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americas Gold and Silver Corporation no par value

USAS

Americas Gold and Silver Corporation no par value

HOLD

Current Price

$5.61

Market Cap

3.2B

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$3.75

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USAS
ATAI
Founded
1998
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
1.3B
IPO Year
2004
2021

Fundamental Metrics

Financial Performance
Metric
USAS
ATAI
Price
$5.61
$3.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
8
Target Price
$4.08
$15.13
AVG Volume (30 Days)
5.7M
3.7M
Earning Date
05-08-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$308,000.00
Revenue This Year
$212.37
N/A
Revenue Next Year
$42.64
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.47
$1.17
52 Week High
$10.50
$6.73

Technical Indicators

Market Signals
Indicator
USAS
ATAI
Relative Strength Index (RSI) 41.37 53.29
Support Level $4.71 $3.57
Resistance Level $6.24 $4.30
Average True Range (ATR) 0.49 0.21
MACD 0.00 0.04
Stochastic Oscillator 59.92 70.92

Price Performance

Historical Comparison
USAS
ATAI

About USAS Americas Gold and Silver Corporation no par value

Americas Gold And Silver Corp is a mining company engaged in the acquisition, exploration, development, and production of precious metals mineral properties in Mexico and the United States. The company's primary operating assets, which are also its reporting segments, are the Cosala operations, the Galena Complex, and Relief Canyon. It also holds interests in the San Felipe Development Project located in Sonora, Mexico. The Cosala operations segment, which derives maximum revenue, operates in Mexico, while the Galena Complex and Relief Canyon segments operate in the United States.

About ATAI ATAI Life Sciences N.V.

AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.

Share on Social Networks: